Tag: AC Immune

November 13, 2018

AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update

AC Immune (NASDAQ:ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced financial results for...
April 5, 2018

AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease

AC Immune (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that...
March 20, 2018

AC Immune reports full-year 2017 financial results

AC Immune (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced...
October 26, 2017

The State of Novel Alzheimer's Treatments

Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a...
September 23, 2016

AC Immune Opens For Trading On NASDAQ

AC Immune, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that its common shares will open...
September 22, 2016

AC Immune SA Announces Pricing of Upsized Initial Public Offering

AC Immune SA announced today the pricing of its initial public offering of 6,000,000 of its common shares at the...
September 13, 2016

AC Immune SA Commences Proposed Initial Public Offering of Common Shares

LAUSANNE, Switzerland, Sept. 13, 2016 (GLOBE NEWSWIRE) — AC Immune SA announced today that it has commenced the initial public...